Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics ; volume:13 ; number:1 ; day:2 ; month:10 ; year:2022 ; pages:1-19 ; date:12.2022
Nature Communications ; 13, Heft 1 (2.10.2022), 1-19, 12.2022

Urheber
Fraser, Cameron S.
Spetz, Johan K. E.
Qin, Xingping
Presser, Adam
Choiniere, Jonathan
Li, Chendi
Yu, Stacey
Blevins, Frances
Hata, Aaron N.
Miller, Jeffrey W.
Bradshaw, Gary A.
Kalocsay, Marian
Sanchorawala, Vaishali
Sarosiek, Shayna
Sarosiek, Kristopher A.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41467-022-33461-z
URN
urn:nbn:de:101:1-2022122021262380030916
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Fraser, Cameron S.
  • Spetz, Johan K. E.
  • Qin, Xingping
  • Presser, Adam
  • Choiniere, Jonathan
  • Li, Chendi
  • Yu, Stacey
  • Blevins, Frances
  • Hata, Aaron N.
  • Miller, Jeffrey W.
  • Bradshaw, Gary A.
  • Kalocsay, Marian
  • Sanchorawala, Vaishali
  • Sarosiek, Shayna
  • Sarosiek, Kristopher A.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics

BH3-mimetics: recent developments in cancer therapy

BH3-mimetics: recent developments in cancer therapy

BH3 mimetics for the treatment of prostate cancer

BH3 mimetics for the treatment of prostate cancer

Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells

Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia

BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

Evaluation of BH3 mimetics as a novel therapeutic strategy in acute myeloid leukemia

Evaluation of BH3 mimetics as a novel therapeutic strategy in acute myeloid leukemia

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells

Verbundene Objekte